The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT).
 
Enrique Soto Perez De Celis
No Relationships to Disclose
 
Daneng Li
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Speakers' Bureau - Lexicon
 
Can-Lan Sun
No Relationships to Disclose
 
Heeyoung Kim
No Relationships to Disclose
 
Przemyslaw Twardowski
No Relationships to Disclose
 
Marwan Fakih
Honoraria - Sirtex Medical
Consulting or Advisory Role - Amgen; Array BioPharma; Genentech/Roche
Speakers' Bureau - Amgen; Taiho Pharmaceutical
Research Funding - Merck (Inst); Novartis (Inst)
 
Vincent M. Chung
Consulting or Advisory Role - Celgene; Five Prime Therapeutics; Ipsen; Perthera
Speakers' Bureau - Celgene
 
Mihaela C. Cristea
No Relationships to Disclose
 
Dean Lim
No Relationships to Disclose
 
Yuan Yuan
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Eisai; Merck; Pfizer
 
William Dale
No Relationships to Disclose
 
Leana Chien
No Relationships to Disclose
 
Kemeberly Charles
No Relationships to Disclose
 
Heidi Tan
No Relationships to Disclose
 
Elsa Roberts
No Relationships to Disclose
 
Jeanine Moreno
No Relationships to Disclose
 
Daisy Rivera
No Relationships to Disclose
 
Vani Katheria
No Relationships to Disclose
 
Arti Hurria
Consulting or Advisory Role - Boehringer Ingelheim; GTx; MJH Healthcare Holdings, LLC; On Q Health; OptumHealth; Pierian Biosciences; Sanofi
Research Funding - Celgene; GlaxoSmithKline; Novartis